Protective effects of dilazep and its novel derivative, K-7259, on mechanical and metabolic derangements induced by hydrogen peroxide in the isolated perfused rat heart

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 565-571

  Hara, Akiyoshi ^a   Abiko, Yasushi ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS[4 (3,4,5 TRIMETHOXYPHENYL)BUTYL]HOMOPIPERAZINE; 8 (4 SULFOPHENYL)THEOPHYLLINE; CORONARY VASODILATING AGENT; CYCLIC AMP; DILAZEP; HYDROGEN PEROXIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HEART PROTECTION; INOTROPISM; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DILAZEP; ENERGY METABOLISM; HEART; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MALE; MYOCARDIUM; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0030437245     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. BERGMEYER, H. U., ED.: Methods of Enzymatic Analysis, pp. 1777-1781, pp. 2101-2110, pp. 2127-2131. Academic Press, New York, 1974.
2. BROWN, J. M., TERADA, L. S., GROSSO, M. A., WHITMANN, G. J., VELASCO, S. E., PATT, A., HARKEN, A. H. AND REPINE, J. E.: Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. J. Clin. Invest. 81: 1297-1301, 1988.
3. CECONI, C., CARGNONI, A., PASINI, E., CONDORELLI, E., CURELLO, S. AND FERRARI, R.: Evaluation of phospholipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury. Am. J. Physiol 260: H1057-H1061, 1991.
4. CORR, P. B., SAFFITZ, J. E. AND SOBEL, B. E.: Lysophospholipids, long chain acylcarnitines and membrane dysfunction in the ischaemic heart. Basic Res. Cardiol. 82: suppl. 1, 199-208, 1987.
5. FISHER, A. B.: Intracellular production of oxygen-derived free radicals. In: Oxygen Radicals and Tissue Injury, ed. by B. Halliwell. pp. 34-39. The Upjohn Company, Bethesda, 1988.
6. HARA, A. AND ABIKO, Y.: Protective effect of hypoxia on mechanical and metabolic changes induced by hydrogen peroxide in rat hearts. Am. J. Physiol. 268: H614-H620, 1995
7. HARA, A., AKAHIRA, M. AND ABIKO, Y.: Effect of K-7259, a novel derivative of dilazep, on cardiovascular actions of adenosine: Comparison with dilazep. Arch. Int. Pharmacodyn. Ther. 330: 66-75, 1995.
8. HARA, A., MATSUMURA, H. AND ABIKO, Y.: Lidocaine attenuates both mechanical and metabolic changes induced by hydrogen peroxide in the rat heart. Am. J Physiol. 265: H1478-H1485, 1993.
9. HASHIZUME, H., AKIYAMA, K. AND ABIKO, Y.: Effects of antiischemic drugs on veratridine-induced hypercontracture in rat cardiac myocytes. Eur. J. Pharmacol. 271: 1-8, 1994.
10. HATTORI, M., OGAWA, K., SATAKE, T., SUGIYAMA, S. AND OZAWA, T.: Depletion of membrane phospholipid and mitochondrial dysfunction associated with coronary reperfusion. Basic Res. Cardiol. 80: 241-250, 1985.
11. HESS, M. L. AND MANSON, N. H.: Molecular oxygen: Friend and foe: The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 16: 969-985, 1984.
12. HOQUE, A. N. E., HOQUE, N., HASHIZUME, H. AND ABIKO, Y.: Cardioprotective effect of K-7259, a new dilazep derivative, in the ischemic-reperfused isolated working rat hearts. Jpn. J. Pharmacol. 67: suppl. I, 121P, 1995a.
13. HOQUE, A. N. E., HOQUE, N., HASHIZUME, H. AND ABIKO, Y.: A study on dilazep: I. Mechanism of anti-isehemic action of dilazep is not coronary vasodilation but decreased cardiac mechanical function in the isolated, working rat heart. Jpn. J. Pharmacol. 67: 225-232, 1995b.
14. HOQUE, A. N. E., HOQUE, N., HASHIZUME, H. AND ABIKO, Y.: A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart. Jpn. J. Pharmacol. 67: 233-241, 1995c.
15. ISHIBASHI, T., HARA, A. AND ABIKO, Y.: Relationship between coronary flow and adenosine release during severe and mild hypoxia in the isolated perfused rat heart with special reference to time-course change. Heart Vessels 3: 113-121, 1987.
16. JOSEPHSON, R. A., SILVERMAN, H. S., LAKATTA, E. G., STERN, M. D. AND ZWEIER, J. L.: Study of the mechanisms of hydrogen peroxide and hydroxyl free radical-induced cellular injury and calcium overload in cardiac myocytes. J. Biol. Chem. 266: 2354-2361, 1991.
17. 1 receptor activation attenuates cardiac injury produced by hydrogen peroxide. Circ. Res. 71: 1101-1110, 1992.
18. KOKITA, N. AND HARA, A.: Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangements in the isolated rat heart. Anesthesiology 84: 117-127, 1996.
19. KOLLER, P. T. AND BERGMANN, S. R.: Reduction of lipid peroxidation in reperfused isolated rabbit hearts by diltiazem. Circ. Res. 65: 838-846, 1989.
20. KONG, Y., LESNEFSKY, E. J., YE, J. AND HORWITZ, L. D.: Prevention of lipid peroxidation does not prevent oxidant-induced myocardial contractile dysfunction. Am. J. Physiol. 267: H2371-H2377, 1994.
21. KOSTER, J. F., SLEE, R. G., ESSED, C. E. AND STAM, H.: Studies on cumen hydroperoxide-induced lipid peroxidation in the isolated perfused rat heart. J. Mol. Cell. Cardiol. 17: 701-708, 1985.
22. 1 receptor mechanism. Am. J. Physiol. 263: H1460-H1465, 1992.
23. LUCCHESI, B. R.: Myocardial ischemia, reperfusion and free radical injury. Am. J. Cardiol. 65: 141-231, 1990.
24. 2 by peroxidized phospholipids. Lipids 28: 505-509, 1993.
25. MECHJI, P., MIDDLETON, K., HASSALL, C. J. S., PHILLIPS, M. I. AND NEWBY, A. C : Evidence for extracellular deamination of adenosine in the rat heart Int. J. Biochem. 20: 1335-1341, 1988.
26. MUSTAFA, S. J.: Effects of coronary vasodilator drugs on the uptake and release of adenosine in cardiac cells. Biochem. Pharmacol. 28: 2617-2624, 1979.
27. NAKAYA, H., TOHSE, N. AND KANNO, M.: Electrophysiological derangements induced by lipid peroxidation in cardiac tissue. Am. J. Physiol. 253: H1089-H1097, 1987.
28. SANDHU, G. S., BURRIER, A. C. AND JANERO, D. R.: Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in isolated guinea pig heart. Am. J. Physiol. 265: H1249-H1256, 1993.
29. SARGENT, C. A , VESTERQVIST, O., OGLETREE, M. L. AND GROVER, G. J.: Effects of endogenous and exogenous lysophosphatidylcholine in isolated perfused rat hearts. J. Mol. Cell. Cardiol. 25: 905-913, 1993.
30. SOBEL, B. E., CORR, P. B., ROBISON, A. K., GOLDSTEIN, R. A., WITKOWSKI, F. X. AND KLEIN, M. S.: Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J. Clin Invest. 62: 546-553, 1978.
31. SUGIYAMA, S., KONDO, T., AJIOKA, M., HATTORI, M., NAGAI, S. AND OZAWA, T.: The effects of dilazep on reperfusion arrhythmias. Arzneim. Forsch. 35: 1802-1804, 1985.
32. VAN BELLE, H.: Nucleoside transport inhibition: A therapeutic approach to cardioprotection via adenosine? Cardiovasc. Res. 27: 68-76, 1993.
33. VAN BELLE, H., GOOSSENS, F. AND WYNANTS, J.: Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. Am. J. Physiol. 252: H886-H893, 1987.
34. 2: Protection of membranes from lipid peroxidation damage. Trends Biochem. Sci. 12: 31-34, 1987.
35. VER DONCK, L. AND BORGERS, M.: Myocardial protection by R56865: A new principle based on prevention of ion channel pathology. Am. J. Physiol. 261: H1828-H1835, 1991.
36. YTREHUS, K. AND HEGSTAD, A. C.: Lipid peroxidation and membrane damage of the heart. Acta Physiol Scand. 142: suppl. 599, 81-91, 1991.
37. ZHAO, Z. Q., MCGEE, D. S., NAKANISHI, K., TOOMBS, C. F., JOHNSTON, W. E., ASHAR, M. S. AND VINTEN-JOHANSEN, J.: Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation 88: 709-719, 1993.